These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 7787888)

  • 1. Position and orientation independent transactivation by c-Myc.
    Packham G; Bello-Fernandez C; Cleveland JL
    Cell Mol Biol Res; 1994; 40(7-8):699-706. PubMed ID: 7787888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. c-Myc and Max transregulate the mouse ornithine decarboxylase promoter through interaction with two downstream CACGTG motifs.
    Tobias KE; Shor J; Kahana C
    Oncogene; 1995 Nov; 11(9):1721-7. PubMed ID: 7478599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do products of the myc proto-oncogene play a role in transcriptional regulation of the prothymosin alpha gene?
    Mol PC; Wang RH; Batey DW; Lee LA; Dang CV; Berger SL
    Mol Cell Biol; 1995 Dec; 15(12):6999-7009. PubMed ID: 8524267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of Mxi1 inhibits the induction of the human ornithine decarboxylase gene by the Myc/Max protein complex.
    Wu S; Peña A; Korcz A; Soprano DR; Soprano KJ
    Oncogene; 1996 Feb; 12(3):621-9. PubMed ID: 8637719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of Myc targets in c-myc and N-myc induced human tumors.
    Ben-Yosef T; Yanuka O; Halle D; Benvenisty N
    Oncogene; 1998 Jul; 17(2):165-71. PubMed ID: 9674700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ECA39 is regulated by c-Myc in human and by a Jun/Fos homolog, Gcn4, in yeast.
    Ben-Yosef T; Yanuka O; Benvenisty N
    Oncogene; 1996 Nov; 13(9):1859-66. PubMed ID: 8934531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bin1 functionally interacts with Myc and inhibits cell proliferation via multiple mechanisms.
    Elliott K; Sakamuro D; Basu A; Du W; Wunner W; Staller P; Gaubatz S; Zhang H; Prochownik E; Eilers M; Prendergast GC
    Oncogene; 1999 Jun; 18(24):3564-73. PubMed ID: 10380878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of ornithine decarboxylase by IL-3 is mediated by sequential c-Myc-independent and c-Myc-dependent pathways.
    Packham G; Cleveland JL
    Oncogene; 1997 Sep; 15(10):1219-32. PubMed ID: 9294616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ornithine decarboxylase gene is a transcriptional target of c-Myc.
    Bello-Fernandez C; Packham G; Cleveland JL
    Proc Natl Acad Sci U S A; 1993 Aug; 90(16):7804-8. PubMed ID: 8356088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transactivation of prothymosin alpha and c-myc promoters by human papillomavirus type 16 E6 protein.
    Kinoshita T; Shirasawa H; Shino Y; Moriya H; Desbarats L; Eilers M; Simizu B
    Virology; 1997 May; 232(1):53-61. PubMed ID: 9185588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Epstein-Barr virus BRLF1 gene product transactivates the murine and human c-myc promoters.
    Gutsch DE; Marcu KB; Kenney SC
    Cell Mol Biol (Noisy-le-grand); 1994 Sep; 40(6):747-60. PubMed ID: 7812182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional activation of the c-myc gene by the c-myb and B-myb gene products.
    Nakagoshi H; Kanei-Ishii C; Sawazaki T; Mizuguchi G; Ishii S
    Oncogene; 1992 Jun; 7(6):1233-40. PubMed ID: 1594249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual control of myc expression through a single DNA binding site targeted by ets family proteins and E2F-1.
    Roussel MF; Davis JN; Cleveland JL; Ghysdael J; Hiebert SW
    Oncogene; 1994 Feb; 9(2):405-15. PubMed ID: 8290253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. c-Myc trans-activates the p53 promoter through a required downstream CACGTG motif.
    Reisman D; Elkind NB; Roy B; Beamon J; Rotter V
    Cell Growth Differ; 1993 Feb; 4(2):57-65. PubMed ID: 8494784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opposite transcriptional activity between the wild type c-myc gene coding for c-Myc1 and c-Myc2 proteins and c-Myc1 and c-Myc2 separately.
    Batsché E; Crémisi C
    Oncogene; 1999 Oct; 18(41):5662-71. PubMed ID: 10523846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of human ornithine decarboxylase expression following prolonged quiescence: role for the c-Myc/Max protein complex.
    Peña A; Wu S; Hickok NJ; Soprano DR; Soprano KJ
    J Cell Physiol; 1995 Feb; 162(2):234-45. PubMed ID: 7822433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myc and Max proteins possess distinct transcriptional activities.
    Kretzner L; Blackwood EM; Eisenman RN
    Nature; 1992 Oct; 359(6394):426-9. PubMed ID: 1406956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional activation by Myc is under negative control by the transcription factor AP-2.
    Gaubatz S; Imhof A; Dosch R; Werner O; Mitchell P; Buettner R; Eilers M
    EMBO J; 1995 Apr; 14(7):1508-19. PubMed ID: 7729426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. hnRNP U interacts with the c-Myc-Max complex on the E-box promoter region inducing the ornithine decarboxylase gene.
    Matsuoka Y; Uehara N; Tsubura A
    Oncol Rep; 2009 Aug; 22(2):249-55. PubMed ID: 19578763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wild-type murine p53 represses transcription from the murine c-myc promoter in a human glial cell line.
    Moberg KH; Tyndall WA; Hall DJ
    J Cell Biochem; 1992 Jun; 49(2):208-15. PubMed ID: 1400626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.